BTS 74,398
BTS 74,398 is a centrally acting stimulant drug which was developed for the treatment of Parkinson's disease. It inhibits the synaptic reuptake of dopamine, serotonin and noradrenaline, making it a triple reuptake inhibitor. It was effective in animal models of Parkinson's disease, but was unsuccessful in human trials.
Wikipage redirect
primaryTopic
BTS 74,398
BTS 74,398 is a centrally acting stimulant drug which was developed for the treatment of Parkinson's disease. It inhibits the synaptic reuptake of dopamine, serotonin and noradrenaline, making it a triple reuptake inhibitor. It was effective in animal models of Parkinson's disease, but was unsuccessful in human trials.
has abstract
BTS 74,398 is a centrally acti ...... unsuccessful in human trials.
@en
IUPAC name
1-([1-(3,4-dichlorophenyl)cyclobutyl]-2-(3-diaminethylaminopropylthio)ethanone
@en
PubChem
thumbnail
Wikipage page ID
19,998,527
Wikipage revision ID
702,419,801
ChemSpiderID
26,325,181
molecular weight
4.18423e+2
smiles
StdInChIKey
OLQJWCYRPYGTJI-UHFFFAOYSA-N
verifiedrevid
472,223,890
comment
BTS 74,398 is a centrally acti ...... unsuccessful in human trials.
@en
label
BTS 74,398
@en
